SPP-002
SPP-002 is a sulfate analogue that acts as a potential Sialyltransferase (ST) inhibitor. SPP-002 selectively inhibits n-glycosialylation with inhibition at least an order of magnitude greater than that of unmodified parental cholic acid (LCA) . SPP-002 reduces tumor cell migration and invasion by inhibiting the integrin /FAK/Paxillin signaling pathway. SPP-002 can be used in the study of tumor metastasis[1].
Product Specifications
UNSPSC
12352211
Target
Sialyltransferase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/spp-002.html
Purity
98.0
Solubility
DMSO : ≥ 25 mg/mL
Smiles
C[C@H](CCCOS(=O)(O[K])=O)[C@H]1CC[C@@]2([H])[C@]3([H])CC[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@]12C
Molecular Formula
C24H41KO5S
Molecular Weight
480.74
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lipolysis Stimulated Lipoprotein Receptor (LSR) Antibody (Biotin)
Lipolysis Stimulated Lipoprotein Receptor (LSR) Antibody (Biotin)
Lipolysis Stimulated Lipoprotein Receptor (LSR) Antibody (Biotin)
Lipolysis Stimulated Lipoprotein Receptor (LSR) Antibody (Biotin)
Lipolysis Stimulated Lipoprotein Receptor (LSR) Antibody (Biotin)
